Present Title & Affiliation Primary Appointment Associate Vice President for Translational Integration, Office of Chief Scientific Officer, The University of Texas MD Anderson Cancer Center, Houston, TX TRACTION Medical Director, Therapeutics Discovery Division, The University of Texas MD Anderson Cancer Center, Houston, TX Professor, Gastrointestinal (GI) Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX Deputy Chair for Translational Research, Gastrointestinal (GI) Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX Dual/Joint/Adjunct Appointment Dr
The platform employs state-of-the-art encryption methods to safeguard sensitive health data, ensuring that patients can interact with their healthcare providers without fear of breaches
To our knowledge, this is the first study to investigate the synergistic effects of semaglutide combined with a phytochemical-rich agent such as papaya on multiple neuroprotective pathways in diabetic encephalopathy
A recent study suggests an increased risk of NAION in patients taking GLP-1 receptor agonists like Mounjaro ( Hathaway et al, 2024 )
Gut 32(1):7379
